Seoul Court accepted interim injunction on test fraud case.
Published: 2006-06-19 07:00:00
Updated: 2006-06-19 07:00:00
The Seoul District Administrative Court has accepted the interim injunction earlier raised by 12 pharmaceutical companies against the KFDA's cancellation and scrap of the product health registration on charge of the manipulated bio equivalency tests.
Now, the KFDA's administrative measures of ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
